Genetic and epigenetic abnormalities, such as NPM1 mutation, DNMT3a mutation, and MLL rearrangement, are determinants of AML pathogenesis and always relate to AML prognosis (4). This evidence concerns the gene DNMT3A and acute myeloid leukemia.